Skip to content

Press Releases

Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Nov 09, 2021

Haemonetics Announces CFO William P. Burke's Retirement for June 2022

Nov 09, 2021

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021

Oct 06, 2021

Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation

Sep 30, 2021

Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference

Aug 25, 2021

Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Aug 11, 2021

Lloyd E. Johnson Joins Haemonetics' Board of Directors; Ellen Zane Announced as New Board Chair

Aug 09, 2021

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021

Jul 09, 2021

Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

May 13, 2021

Peer-Reviewed Results of Haemonetics' Improving Plasma Collection (IMPACT) Trial Published in the Journal TRANSFUSION

Apr 29, 2021

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021 Results: May 13, 2021

Apr 23, 2021

Haemonetics Provides Update On U.S. Plasma Business

Apr 19, 2021